The Effect of TENS on Early Patient Outcomes After Total Knee Arthroplasty
Launched by CUKUROVA UNIVERSITY ·
Trial Information
Current as of November 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This trial is testing whether adding transcutaneous electrical nerve stimulation (TENS) to usual after-surgery care can help with early pain after total knee replacement. In this randomized study, adults who are having their first knee replacement will receive TENS (a low‑voltage electrical device) twice a day for 30 minutes within the first 24 hours after surgery, in addition to standard care, while others receive standard care alone. The main thing the researchers are measuring is pain in the first 24 hours after surgery, using a questionnaire that also looks at how pain affects daily activities, sleep, and satisfaction with pain relief.
Eligible participants are adults 18 and older undergoing their first total knee replacement, who do not have chronic pain, are able to communicate well, have no serious psychological distress, and have no medical reasons that would prevent TENS (such as a pacemaker or epilepsy). About 44 people are planned to enroll at Adana City Training and Research Hospital in Turkey, led by Cukurova University. The study is currently enrolling by invitation and is not blinded, so participants and clinicians will know which treatment group they are in. Results are not yet available.
Gender
ALL
Eligibility criteria
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported